amitifadine (EB-1010) / Ethismos Research  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
amitifadine (EB-1010) / Ethismos Research
NCT00659347: Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder

Terminated
2
200
US, Europe, RoW
DOV 21, 947, Placebo
DOV Pharmaceutical, Inc.
Major Depressive Disorder
12/08
12/08

Download Options